Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0318266 ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE
A substituted alkenylbenzene compound of formula (4): ##STR00001## wherein X.sup.1 is selected from the group consisting of a halogen atom, --SF.sub.5,...
2018/0318265 USE OF ISOXAZOLINE COMPOUNDS FOR TREATING DEMODICOSIS
The present invention relates to methods of treating demodicosis by administering an isoxazoline compound of formula (I) ##STR00001##
2018/0318264 OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO
The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure...
2018/0318263 TREATMENT OF PROSTATE CANCER CELLS WITH FAT OXIDATION INHIBITORS AND ENZALUTAMIDE
A combination therapy for the treatment of cancers refractory to anti-androgen therapy; particularly prostate cancer. The combination therapy includes a...
2018/0318262 THIOUREYLENE LIQUID COMPOSITIONS
The present invention relates to novel liquid compositions and formulations containing a thioureylene compound, a polysaccharide and a liquid vehicle. The...
2018/0318261 USE OF COMPOSITION FOR PREPARING A MEDICAMENT FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
The present invention relates to the use of a composition for preparing a medicament for the treatment of amyotrophic lateral sclerosis and associated...
2018/0318260 COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
This invention provides compositions and methods for restoring proper folding and function of Cystic Fibrosis Transmembrane Conductance Regulator mutant with...
2018/0318259 COMPLEX OF ANGIOTENSIN RECEPTOR ANTAGONIST AND NEUTRAL ENDOPEPTIDASE INHIBITOR
Provided a complex of formula is [3-((1S, 3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate-(S)-3'-methyl-2'-(pentanoyl...
2018/0318258 Molecules in the Tryptophan-5-Hydroxytryptophan-Serotonin-NAS-Melatonin/6-Hydroxymelatonin ...
Methods that include determining levels of melatonin pathway agents (melatonin, L-tryptophan, 5-hydroxytryptophan (5-HTP), serotonin, N-acetylserotonin (NAS),...
2018/0318257 PDE4 MODULATORS FOR TREATING AND PREVENTING IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS)
Methods of treating immune reconstitution inflammatory syndrome (IRIS) in immunodeficient patients, including HIV patients, using PDE4 modulators are described.
2018/0318256 FORMULATIONS WITH REDUCED OXIDATION
The invention provides formulations comprising a protein in combination with a compound that prevents oxidation of the protein. The invention also provides...
2018/0318255 Pro-Neurogenic Compounds
This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and...
2018/0318254 Pyrrolidine Derivatives
Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the...
2018/0318253 Ameliorating Periodontitis by Local Treatment with Warfarin and/or Other Vitamin K Oxide Reductase Inhibitors
A new indication for the Warfarin family of drugs is described. In patients suffering from chronic periodontitis, continued systemic medication with Warfarin...
2018/0318252 COMPOSITIONS FAVORING WOUND REPAIR
Disclosed are methods of favouring epithelial wound healing in a subject. Wounds suitable for this method include wounds located on the skin or in a cornea The...
2018/0318251 PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
The present invention relates to methods for preventing or treating acute or chronic heart failure and for reducing the risk of cardiovascular death,...
2018/0318250 Method for Transnasal Delivery of Blood-Brain Barrier Permeation Agent and Therapeutic Agent
Described herein is a method for treating a central nervous system disorder, said method comprising steps of first transnasally administering to or immediately...
2018/0318249 COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN
Pharmaceutical formulations containing busulfan and cyclodextrin are described. The formulation can include busulfan and cyclodextrin in a clear aqueous...
2018/0318248 10-HYDROXY-CIS-12-OCTADECENOIC ACID ALKYL ESTER AND USE THEREOF
The invention provides a HYA derivative having superior physiological functions intrinsic to HYA and permitting easy ingestion and easy handling, and use...
2018/0318247 CATIONIC ANTIMICROBIAL HANDWASH
An antimicrobial composition is provided that includes from about 0.1 to about 2 wt. % of a cationic antimicrobial agent selected from the group consisting of...
2018/0318246 PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
The present invention relates to pharmaceutical composition comprising dimethyl fumarate; an enzyme modulator or a permeation enhancer or both; and one or more...
2018/0318245 ISOTRETINOIN FORMULATIONS AND USES AND METHODS THEREOF
Provided herein are novel isotretinoin formulations that provide an enhanced targeted dermal delivery system for the drug isotretinoin with improved...
2018/0318244 MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS
Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism,...
2018/0318243 USE OF LITHIUM BENZOATE FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS
Methods for treating central nervous system (CNS) disorders or attenuating pain with a lithium benzoate compound.
2018/0318242 METHOD OF TREATING TEMPOROMANDIBULAR JOINT DISORDERS
The present disclosure generally relates to methods for treating temporomandibular joint disorders. More particularly, the disclosure pertains to topical...
2018/0318241 TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS
The present specification provides methods of treating nervous system disorders with a thyroid hormone neutral dose of a RXR agonist to promote remyelination...
2018/0318240 AMINO-ARYL-BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOF
A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses...
2018/0318239 METHODS AND COMPOSITIONS FOR IMPROVING EYE HEALTH
Provided herein are methods of treating glaucoma in a patient, comprising: obtaining a biological sample from the patient; testing the biological sample for...
2018/0318238 METHODS FOR REDUCING SEQUELAE OF INTRA-DIALYTIC HYPOTENSION
Provided are methods for using S-alkylisothiouronium derivatives, including S-ethylisothiouronium diethylphosphate, to alleviate, prevent and/or reduce a...
2018/0318237 TOPICAL REGIONAL NEURO-AFFECTIVE THERAPY IN MAMMALS WITH CANNABINOIDS
A method of treating a disease state or condition in mammals other than humans via topical brainstem afferent stimulation therapy via the administration of a...
2018/0318236 SYSTEMS AND METHODS FOR FEEDING SUGAR ALCOHOL TO RUMINANTS DURING PERIODS OF HEAT STRESS
Systems and methods provide sugar alcohol to heat stressed ruminants to improve performance. During periods of high temperature or humidity, heat stressed...
2018/0318235 Zeaxanthin for Tumor Treatment
A composition comprising a pharmaceutically effective amount of zeaxanthin or its derivative for use in treating a malignant tumor and a method of using a...
2018/0318234 PURGATIVE COMPOSITION FOR CLEANSING INTESTINAL TRACT
The present invention relates to a purgative composition for cleansing an intestinal tract and, specifically, to a purgative composition for cleansing an...
2018/0318233 DRUG DELIVERY COMPOSITION CONTAINING SILYL POLYMERS
The invention relates to a silyl-containing polymer that is used, together with a tackifying resin to form an adhesive composition capable of storing and...
2018/0318232 FORMULATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING FENTANYL AND ANALOGUE THEREOF
Disclosed is a transdermal preparation, comprising sequentially-stacked layers of a backing layer, a barrier layer, a drug adhesive layer and a release layer,...
2018/0318231 CATIONIC MATERIALS AND FORMULATIONS FOR DRUG DELIVERY
Cationic polymers are provided for delivering anionic active agents, preferably in the form or nanoparticles and other nanostructures. The polymer can be a...
2018/0318229 COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of combinations of immunomodulatory polynucleotides...
2018/0318228 METHOD FOR A SLOW RELEASE OF DRUGS FROM ORALLY DISSOLVING CAPSULES
A method for a slow-release of drugs from orally dissolving capsule has been described. It releases medicaments in the mouth cavity up to 1 hour. The...
2018/0318227 TAMPERPROOF DOSAGE FORM
A tamperproof dosage form for oral administration comprising a cap and a body each comprising an outer surface and an inner surface, the cap and body being...
2018/0318226 Drug Delivery with Orally Dissolving Capsules
A slow-release orally dissolving capsule has been described, which releases medicaments in the mouth cavity up to 1 hour. The medicaments may have a...
2018/0318225 CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION
Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure...
2018/0318224 Directly compressible composition comprising microcrystalline cellulose
The present invention relates to a directly compressible composition for the production of tablets which comprise fine-grained polyvinyl alcohols (PVAs) and...
2018/0318223 ABUSE-PROOFED DOSAGE FORM
A solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active...
2018/0318222 CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that...
2018/0318221 COLCHICINE SALICYLATE DERIVATIVES AND METHODS OF TREATMENT
Pharmaceutical compositions of colchicine salicylate, including once-a-day orally administered formulations are provided. Method of treating and/or preventing...
2018/0318220 PARTICLES, PHARMACEUTICAL PREPARATION, TOPICAL DRUG, AND COSMETIC PRODUCT
Provided are an active ingredient-containing particle with improved shape retainability. The particle includes a first fraction containing an active...
2018/0318219 LIPOSOMAL CISPLATIN COMPOSITIONS FOR CANCER THERAPY
The present invention provides a composition for the treatment of cancer including zwitterionic liposomes consisting essentially of: 50-65 mol % of a...
2018/0318218 NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA
Nanolipoprotein particles comprising at least a scaffold protein component and a membrane lipid component and related complexes, compositions, methods and...
2018/0318217 Liposomal Curcumin for Treatment of Diseases
The present invention provides compositions and methods for the treatment of a human patient. The methods and compositions of the present invention include...
2018/0318216 DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY
In various embodiments deformable nano-scale vehicles (DNV) are provided that are useful for the delivery of therapeutic agents. In certain embodiments the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.